{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:03:57Z","timestamp":1784124237391,"version":"3.55.0"},"reference-count":32,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The FUNPAR Foundation, Ministry of Education\u2014Brazil and Federal University of Paran\u00e1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n               <jats:title>Background<\/jats:title>\n               <jats:p>COVID-19 is an infectious pathology that shows vascular changes during pregnancy, as well as in the placentas. The main objectives of this study were to estimate the prevalence and the risk factors for preeclampsia in hospitalized pregnant women with COVID-19. As well as comparing maternal and perinatal outcomes in hospitalized pregnant women with COVID-19 and preeclampsia with those without preeclampsia.<\/jats:p>\n            <\/jats:sec>\n            <jats:sec>\n               <jats:title>Methods<\/jats:title>\n               <jats:p>Prospective cohort study of 100 hospitalized pregnant women from two tertiary hospitals, diagnosed with COVID-19, and divided into two groups: PE+ group (pregnant women with COVID-19 and preeclampsia) and PE- group (pregnant women with COVID-19 without preeclampsia). These pregnant women had prevalence, risk factors, maternal and perinatal data analyzed.<\/jats:p>\n            <\/jats:sec>\n            <jats:sec>\n               <jats:title>Results<\/jats:title>\n               <jats:p>The prevalence of preeclampsia was 11%. Severe COVID-19 was the main risk factor for preeclampsia (OR = 8.18 [CI 1.53\u201343.52]), as well as fetal growth restriction was the main perinatal outcome (OR = 8.90 [CI 1.52\u201338.4]). Comorbidities were more frequent in the PE+ group (63.6% <jats:italic>vs<\/jats:italic> 31.5%, <jats:italic>p<\/jats:italic>\u00a0=\u00a00.03), as well as prematurity (81.8% <jats:italic>vs<\/jats:italic> 41.6%, <jats:italic>p<\/jats:italic>\u00a0=\u00a00.02), low birth weight (63.6% <jats:italic>vs<\/jats:italic> 24.7%, <jats:italic>p<\/jats:italic>\u00a0=\u00a00.01), and the need for neonatal intensive care admission of the newborn (63.6% <jats:italic>vs<\/jats:italic> 27.0%, <jats:italic>p<\/jats:italic>\u00a0=\u00a00.03). Pregnant women with PE had twice as long a length of stay in the intensive care unit (RR = 2.35 [CI 1.34\u20134.14]). Although maternal mortality was more frequent among pregnant women with PE, it was not statistically significant.<\/jats:p>\n            <\/jats:sec>\n            <jats:sec>\n               <jats:title>Conclusions<\/jats:title>\n               <jats:p>Prevalence of preeclampsia in hospitalized pregnant women with COVID-19 was 11%. Severe COVID-19 was the main risk factor for preeclampsia and associated comorbidities increased the risk for developing preeclampsia. Long length of stay in the intensive care unit was the main maternal outcome and fetal growth restriction was the main perinatal outcome of preeclampsia.<\/jats:p>\n            <\/jats:sec>","DOI":"10.7717\/peerj.17481","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T07:08:27Z","timestamp":1718089707000},"page":"e17481","source":"Crossref","is-referenced-by-count":5,"title":["Preeclampsia in pregnant women with COVID-19: a prospective cohort study from two tertiary hospitals in Southern Brazil"],"prefix":"10.7717","volume":"12","author":[{"given":"Narcizo LEC","family":"Sobieray","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology and Postgraduate Program in Internal Medicine and Health Sciences, Universidade Federal do Paran\u00e1, Curitiba, Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Newton S.","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology and Postgraduate Program in Obstetrics and Gynecology, Universidade Federal do Paran\u00e1, Curitiba, Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia F.","family":"Klas","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Hospital of Clinics Complex\u2014CHC-UFPR-EBSERH, Universidade Federal do Paran\u00e1, Curitiba, Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella N.","family":"Furuie","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Hospital of Clinics Complex\u2014CHC-UFPR-EBSERH, Universidade Federal do Paran\u00e1, Curitiba, Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jullie A.","family":"Chiste","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Hospital of Clinics Complex\u2014CHC-UFPR-EBSERH, Universidade Federal do Paran\u00e1, Curitiba, Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyllian A.","family":"Fuga\u00e7a","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Hospital of Clinics Complex\u2014CHC-UFPR-EBSERH, Universidade Federal do Paran\u00e1, Curitiba, Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica S.","family":"Longo","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Hospital of Clinics Complex\u2014CHC-UFPR-EBSERH, Universidade Federal do Paran\u00e1, Curitiba, Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana D.","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Hospital Nossa Senhora das Gra\u00e7as, Curitiba, Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio L.","family":"Padilha","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Postgraduate Program in Internal Medicine and Helath Sciences, Universidade Federal do Paran\u00e1, Curitiba, Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4443","published-online":{"date-parts":[[2024,6,11]]},"reference":[{"issue":"3","key":"10.7717\/peerj.17481\/ref-1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3390\/vaccines12030222","article-title":"A comprehensive review of neurodegenerative manifestations of SARS-CoV-2","volume":"12","author":"Bedran","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.7717\/peerj.17481\/ref-2","article-title":"COVID-19 observatory extraordinary bulletin","author":"BRAZIL MH\u00a0FIOCRUZ","year":"2021"},{"key":"10.7717\/peerj.17481\/ref-3","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.ejogrb.2020.07.005","article-title":"Proteinuria in COVID-19 pregnant women: preeclampsia or severe infection?","volume":"252","author":"Dap","year":"2020","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"issue":"11","key":"10.7717\/peerj.17481\/ref-4","doi-asserted-by":"publisher","first-page":"1003857","DOI":"10.1371\/journal.pmed.1003857","article-title":"Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: a national retrospective cohort study","volume":"18","author":"Epelboin","year":"2021","journal-title":"PLOS Medicine"},{"key":"10.7717\/peerj.17481\/ref-5","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.10.20133801","article-title":"COVID-19 causing HELLP-like syndrome in pregnancy and role of angiogenic factors for differential diagnosis","author":"Figueras","year":"2020"},{"issue":"5","key":"10.7717\/peerj.17481\/ref-6","doi-asserted-by":"publisher","first-page":"e97401","DOI":"10.1371\/journal.pone.0097401","article-title":"The burden of eclampsia: results from a multicenter study on surveillance of severe maternal morbidity in Brazil","volume":"9","author":"Giordano","year":"2014","journal-title":"PLOS ONE"},{"key":"10.7717\/peerj.17481\/ref-7","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.preghy.2022.05.005","article-title":"Preeclampsia among women with COVID-19 during pregnancy and its impact on maternal and perinatal outcomes: results from a national multicenter study on COVID in Brazil, the REBRACO Initiative","volume":"28","author":"Guida","year":"2022","journal-title":"Pregnancy Hypertens"},{"key":"10.7717\/peerj.17481\/ref-8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.preghy.2021.11.001","article-title":"Is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?","volume":"27","author":"Hantoushzadeh","year":"2022","journal-title":"Pregnancy Hypertens"},{"issue":"S1","key":"10.7717\/peerj.17481\/ref-9","doi-asserted-by":"crossref","first-page":"PMC9347992","DOI":"10.1096\/fasebj.2022.36.S1.R5913","article-title":"The role of B cells in mediating hypertension in preeclampsia or COVID-19 inf during pregnancy","volume":"36","author":"Herrock","year":"2022","journal-title":"FASEB Journal"},{"key":"10.7717\/peerj.17481\/ref-10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.preghy.2021.07.248","article-title":"Who said differentiating preeclampsia from COVID-19 infection was easy?","volume":"26","author":"Jayaram","year":"2021","journal-title":"Pregnancy Hypertension"},{"issue":"3","key":"10.7717\/peerj.17481\/ref-11","doi-asserted-by":"publisher","first-page":"224","DOI":"10.4274\/tjod.galenos.2021.66750","article-title":"A meta-analysis for the risk and prevalence of preeclampsia among pregnant women with COVID-19","volume":"18","author":"Karimi-Zarchi","year":"2021","journal-title":"Turkish Journal Of Obstetrics and Gynecology"},{"issue":"6","key":"10.7717\/peerj.17481\/ref-12","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.ajog.2021.08.020","article-title":"SARS-CoV-2 and the subsequent development of preeclampsia and preterm birth: evidence of a dose\u2014response relationship supporting causality","volume":"225","author":"Lai","year":"2021","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.7717\/peerj.17481\/ref-13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.coph.2011.01.003","article-title":"Role of angiotensin II type1 receptor agonist autoantibodies (AT1AA) in preeclampsia","volume":"11","author":"Lamarca","year":"2011","journal-title":"Current Opinion in Pharmacology"},{"issue":"4","key":"10.7717\/peerj.17481\/ref-14","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/AOG.0000000000000472","article-title":"Maternal morbidity associated with early-onset and late-onset preeclampsia","volume":"124","author":"Lisonkova","year":"2014","journal-title":"Obstetrics and Gynecology"},{"issue":"11","key":"10.7717\/peerj.17481\/ref-15","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1111\/1471-0528.16339","article-title":"Pre-eclampsia-like syndrome induced by severe COVID-19: a prospective observational study","volume":"127","author":"Mendoza","year":"2020","journal-title":"BJOG"},{"key":"10.7717\/peerj.17481\/ref-16","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/AOG.0000000000004339","article-title":"Disease severity and perinatal outcomes of pregnant patients with coronav\u00edrus disease 2019","volume":"137","author":"Metz","year":"2021","journal-title":"Obstetrics and Gynecology"},{"key":"10.7717\/peerj.17481\/ref-17","article-title":"Newborn health care: guide for health professionals (Vol. IV) - 2023","author":"Minist\u00e9rio da Sa\u00fade Brazil","year":"2023"},{"key":"10.7717\/peerj.17481\/ref-18","article-title":"Manual of recommendations and assistance for pregnant women and postpartum woman facing the COVID-19 Pandemic. Note 13\/2020","author":"Ministry of Health","year":"2023"},{"key":"10.7717\/peerj.17481\/ref-19","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"suppl.1","key":"10.7717\/peerj.17481\/ref-20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO). Initiative on preeclampsia: a pragmatic guide for first-trimester screening and prevention","volume":"145","author":"Poon","year":"2019","journal-title":"International Journal of Gynecology & Obstetrics"},{"key":"10.7717\/peerj.17481\/ref-21","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1111\/aogs.14130","article-title":"Effect of SARS-CoV-2 infection during the second half of pregnancy on fetal growth and hemodynamics: a prospective study","volume":"100","author":"Rizzo","year":"2021","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"3S2","key":"10.7717\/peerj.17481\/ref-22","first-page":"e1445057","article-title":"HELLP syndrome and disseminated intravascular coagulation (DIC) in COVID-19 pregnancy: hemostatic balance challenge","volume":"133","author":"Sanchez","year":"2021","journal-title":"Anesthesia and Analgesia"},{"issue":"5","key":"10.7717\/peerj.17481\/ref-23","first-page":"e25346691","article-title":"Endothelial dysfunction and preeclampsia: role of oxidative stress","volume":"10","author":"S\u00e1nchez-Aranguren","year":"2014","journal-title":"Frontiers in Physiology"},{"issue":"5 Pt 1","key":"10.7717\/peerj.17481\/ref-24","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1097\/01.AOG.0000126245.35811.2a","article-title":"Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count","volume":"103","author":"Sibai","year":"2004","journal-title":"Obstetrics and Gynecology"},{"key":"10.7717\/peerj.17481\/ref-25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2023.02.005","article-title":"HELLP syndrome and COVID-19: a minor revision of a new COVID-19-linked HELLP-like syndrome","author":"Sobieray","year":"2023","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"issue":"9","key":"10.7717\/peerj.17481\/ref-26","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1097\/HJH.0000000000003213","article-title":"Preeclampsia and severe acute respiratory syndrome coronavirus 2 infection: a systematic review","volume":"40","author":"Tossetta","year":"2022","journal-title":"Journal of Hypertension"},{"issue":"11","key":"10.7717\/peerj.17481\/ref-27","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.3390\/cells12111545","article-title":"Modulation of NRF2\/KEAP1 signaling in preeclampsia","volume":"12","author":"Tossetta","year":"2023","journal-title":"Cell"},{"issue":"9","key":"10.7717\/peerj.17481\/ref-28","doi-asserted-by":"publisher","first-page":"003540","DOI":"10.12890\/2022_003540","article-title":"Overlapping presentations of HELLP syndrome and COVID-19","volume":"9","author":"Tou","year":"2022","journal-title":"European Journal of Case Reports in Internal Medicine"},{"issue":"9","key":"10.7717\/peerj.17481\/ref-29","doi-asserted-by":"publisher","first-page":"102459","DOI":"10.1016\/j.jogoh.2022.102459","article-title":"Risk of preeclampsia in patients with symptomatic COVID-19 infection","volume":"51","author":"Tran","year":"2022","journal-title":"Journal of Gynecology Obstetrics and Human Reproduction"},{"issue":"2","key":"10.7717\/peerj.17481\/ref-30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0002-9378(16)32330-4","article-title":"Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy","volume":"142","author":"Weinstein","year":"1982","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.7717\/peerj.17481\/ref-31","article-title":"Preterm birth","author":"WHO","year":"2022"},{"issue":"1","key":"10.7717\/peerj.17481\/ref-32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1: PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"New England Journal of Medicine"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/17481.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/17481.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/17481.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/17481.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T07:08:42Z","timestamp":1718089722000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/17481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,11]]},"references-count":32,"alternative-id":["10.7717\/peerj.17481"],"URL":"https:\/\/doi.org\/10.7717\/peerj.17481","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,11]]},"article-number":"e17481"}}